Home » Stocks » SWKH

SWK Holdings Corporation (SWKH)

Stock Price: $16.10 USD 0.17 (1.07%)
Updated May 18, 2021 12:20 PM EDT - Market open
Market Cap 203.84M
Revenue (ttm) 38.81M
Net Income (ttm) 13.25M
Shares Out 12.80M
EPS (ttm) 0.40
PE Ratio 40.25
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 18
Last Price $16.10
Previous Close $15.93
Change ($) 0.17
Change (%) 1.07%
Day's Open 15.79
Day's Range 15.68 - 16.57
Day's Volume 13,328
52-Week Range 11.56 - 17.70

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

DALLAS, May 17, 2021 /PRNewswire/ -- Corporate Updates YTD SWK has closed two financings totaling up to $14.0 million Enteris BioPharma subsidiary announced completion of manufacturing facility expansio...

20 hours ago - PRNewsWire

DALLAS, May 17, 2021 /PRNewswire/ -- The Board of Directors (the "Board") of SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") and its controlling stockholder, funds affiliated with Carls...

20 hours ago - PRNewsWire

Top Ranked Value Stocks to Buy for May 4th

Other stocks mentioned: BZH, LPX, TSE
2 weeks ago - Zacks Investment Research

BOONTON, N.J., May 3, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidi...

2 weeks ago - PRNewsWire

New Strong Buy Stocks for April 7th

Other stocks mentioned: CENT, LPX, PAG, UFS
1 month ago - Zacks Investment Research

DALLAS, April 6, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") confirmed that on April 5, 2021, a Special Committee (the "Special Committee") of the Company's Boa...

1 month ago - PRNewsWire

DALLAS, March 31, 2021 /PRNewswire/ -- Corporate Highlights Closed four transactions in 2020 deploying $34.8 million; additional $8.1 million deployed to existing borrowers Income producing assets as of...

1 month ago - PRNewsWire

POMPANO BEACH, Fla., March 24, 2021 /PRNewswire/ -- Sincerus Pharmaceuticals, the parent company of Prescriber's Choice and Sincerus Florida, today announced the completion of a major new round of growt...

1 month ago - PRNewsWire

BOONTON, N.J., March 16, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subs...

2 months ago - PRNewsWire

DALLAS, March 15, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today annou...

2 months ago - PRNewsWire

SWKH vs. LU: Which Stock Is the Better Value Option?

Other stocks mentioned: LU
3 months ago - Zacks Investment Research

DALLAS, Feb. 16, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today provide...

3 months ago - PRNewsWire

SWKH vs. RCM: Which Stock Is the Better Value Option?

Other stocks mentioned: RCM
3 months ago - Zacks Investment Research

MOUNT OLIVE, N.J., Jan. 4, 2021 /PRNewswire/ -- Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation (Nasdaq: ...

4 months ago - PRNewsWire

DALLAS, Dec. 24, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announ...

4 months ago - PRNewsWire

DALLAS, Nov. 13, 2020 /PRNewswire/ -- Corporate Highlights Enteris BioPharma, Inc., ("Enteris") a wholly-owned subsidiary of SWK Holdings, recognized $2.5 million in milestone revenue under the license ...

6 months ago - PRNewsWire

DALLAS, Nov. 11, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Bl...

6 months ago - PRNewsWire

DALLAS, Oct. 27, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announ...

6 months ago - PRNewsWire

DALLAS, Sept. 15, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston B...

8 months ago - PRNewsWire

BOONTON, N.J., Sept. 15, 2020 /PRNewswire/ -- Enteris BioPharma, Inc.

8 months ago - PRNewsWire

DALLAS, Sept. 9, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Bl...

8 months ago - PRNewsWire

SWK Holdings Corporation (SWKH) CEO Winston Black on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

DALLAS, Aug. 14, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced that the Company will host a conference call and live audio web...

9 months ago - PRNewsWire

DALLAS, June 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today that Chairman and CEO Winston Black will present via webc...

10 months ago - PRNewsWire

About SWKH

SWK Holdings Corporation, a specialty finance company, focuses on the healthcare sector. The company operates in two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory services... [Read more...]

Industry
Asset Management
IPO Date
Sep 22, 1999
Stock Exchange
NASDAQ
Ticker Symbol
SWKH
Full Company Profile

Financial Performance

In 2020, SWK Holdings's revenue was $36.71 million, an increase of 19.40% compared to the previous year's $30.75 million. Earnings were $5.20 million, a decrease of -78.17%.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for SWK Holdings stock is "Buy." The 12-month stock price forecast is 25.00, which is an increase of 55.28% from the latest price.

Price Target
$25.00
(55.28% upside)
Analyst Consensus: Buy